GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 34 filers reported holding GT BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36 | -99.5% | 150 | -99.3% | 0.00% | – |
| Q2 2023 | $7,186 | -87.2% | 23,030 | -77.4% | 0.00% | – |
| Q1 2023 | $55,970 | +23.0% | 101,764 | +100.0% | 0.00% | – |
| Q4 2022 | $45,494 | -50.0% | 50,882 | -1.7% | 0.00% | – |
| Q3 2022 | $91,000 | -44.8% | 51,740 | -6.3% | 0.00% | – |
| Q2 2022 | $165,000 | +11.5% | 55,225 | +7.6% | 0.00% | – |
| Q1 2022 | $148,000 | +14700.0% | 51,345 | +40329.1% | 0.00% | – |
| Q3 2021 | $1,000 | – | 127 | +370.4% | 0.00% | – |
| Q2 2021 | $0 | – | 27 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silverleafe Capital Partners, LLC | 105,000 | $708,000 | 0.28% |
| Welch Group, LLC | 10,000 | $67,000 | 0.01% |
| Cubist Systematic Strategies, LLC | 33,703 | $227,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 14,260 | $96,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 15,000 | $101,000 | 0.00% |
| ExodusPoint Capital Management, LP | 22,200 | $150,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 162,823 | $1,097,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 51,100 | $344,000 | 0.00% |
| TimeScale Financial, Inc. | 549 | $4,000 | 0.00% |
| Hartford Financial Management Inc. | 500 | $3,000 | 0.00% |